Impact of Androgen Deprivation Therapy Associated to Conformal Radiotherapy in the Treatment of D'Amico Intermediate-/High-Risk Prostate Cancer in Older Patients.
Anne-Laure CoudercEmanuel NicolasRomain BoissierMohammed BoucekineCyrille BastideDelphine BadinandDominique RossiBenedicte MugnierPatrick VillaniGilles KarsentyDidier CowenEric LechevallierXavier MuracciolePublished in: Cancers (2020)
Age ≥80 years should not be a limitation for the treatment of IR and HR prostate cancer patients with 3D-CEBRT and ADT, but cardiovascular monitoring and prevention are mandatory.